Stock Price Quote

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE3197.45-18.65 (-0.58 %)
PREV CLOSE ( ) 3216.10
OPEN PRICE ( ) 3210.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11379
TODAY'S LOW / HIGH ( )3167.50 3259.75
52 WK LOW / HIGH ( )1520 3398.95
NSE3194.75-21.7 (-0.67 %)
PREV CLOSE( ) 3216.45
OPEN PRICE ( ) 3215.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3194.75 (332)
VOLUME 250604
TODAY'S LOW / HIGH( ) 3165.00 3260.00
52 WK LOW / HIGH ( )1516 3399.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-02 1995
Management Info
Arvind Lal - Chairman Om Prakash Manchanda - Managing Director
Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 91-011-3024 4149

Email ved.goel@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE

NEWS

14Jun Dr. Lal PathLabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
11Jun Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
08Jun Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
03Jun Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
02Jun Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit7872801
Gross Profit 1047 3741
Operating Profit 12654587
Net Sales 404114905

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thyrocare Tech. (BSE)
peergroup  1249.95 (1.94%)
M.Cap ( in Cr)6609.04
Shalby (BSE)
peergroup  165.20 (2.61%)
M.Cap ( in Cr)1784.32
Medinova Diagnostic (BSE)
peergroup  47.10 (4.90%)
M.Cap ( in Cr)47.01
Constronics Infra (BSE)
peergroup  6.22 (4.89%)
M.Cap ( in Cr)4.48
Transgene Biotek (BSE)
peergroup  5.41 (4.44%)
M.Cap ( in Cr)40.99

Shareholding Pattern

PROMOTERS 55.23%
MUTUAL FUNDS/UTI 5.31%
NON-INSTITUTION 11.23%
FI/BANKS/INSURANCE 1.17%
GOVERNMENT 0%
FII 0%

About Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd. was incorporated in the year 1995. Its today's share price is 3197.45. Its current market capitalisation stands at Rs 26649.11 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12735.98 Cr and Total Income of Rs.13312.07 Cr. The company's management includes Anoop Singh, Rajat Kalra, Archana Lal Erdmann, Rahul Sharma, Harneet Singh Chandhoke, Somya Satsangi, Saurabh Srivastava, Sunil Varma, Vandana Lal, Om Prakash Manchanda, Arvind Lal.

It is listed on the BSE with a BSE Code of 539524 , NSE with an NSE Symbol of LALPATHLAB and ISIN of INE600L01024. It's Registered office is at Block E,Sector 18,RohiniNew Delhi-110085, Delhi. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)